Sabra Reports Fourth Quarter 2017 Results; Closes on Enlivant Investments; Provides Update on CCP Merger Execution; Provides Update on Genesis Exodus; Updates 2018 Earnings Guidance

Go back to Sabra Reports Fourth Quarter 2017 Results; Closes on Enlivant Investments; Provides Update on CCP Merger Execution; Provides Update on Genesis Exodus; Updates 2018 Earnings Guidance

Sabra Healthcare REIT Inc. (SBRA) PT Lowered to $21 at Stifel

February 22, 2018 6:57 AM EST

Stifel lowered its price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $21.00 (from $22.00) while maintaining a Hold rating.

... More